T1	Participants 71 98	patients with hypertension:
T2	Participants 299 342	patients with mild to moderate hypertension
T3	Participants 494 804	132 subjects in this randomized, controlled trial were in the age range of 40-79 years. The inclusion criteria were: systolic BP (SBP) ranging from 140-179 mm Hg and/or diastolic BP (DBP) ranging from 90-99 mm Hg and treatment-naive (untreated for hypertension); or on a regimen of medication for hypertension.
T4	Participants 814 905	132 subjects, 124 (94%) were already receiving treatment with antihypertensive medications.